Earnings Call · Q2 FY2021·2021-08-05

Q2 21EPS -6.45%·Rev n/aQ1 21EPS -10.34%·Rev n/aQ4 20EPS -38.10%·Rev n/aQ3 20EPS +96.00%·Rev n/a⚠ consensus missing

SANGAMO THERAPEUTICS, INC SGMO

Aron Feingold — Head of Corporate Communications

Sandy Macrae — Chief Executive Officer

Prathyusha Duraibabu — Chief Financial Officer

−2.1%1d on move date−2.3% vs SPY3d+1.5%5d+2.4%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SGMO calls or request research access.

More SGMO calls Browse calls Request research access